The Role of Pharmacoepidemiology in Regulatory Agencies

Gerald J Dal Pan, Peter Arlett

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The data sources and methods that underlie the discipline of pharmacoepidemiology have expanded greatly over the past several decades. This growth has involved academia, industry, and regulatory agencies. For drug regulatory agencies, pharmacoepidemiology is a core scientific discipline. Three key issues are highlighted that are of particular importance to drug regulators: using pharmacoepidemiology throughout a product's lifecycle; developing approaches to synthesize data from multiple sources; and building capacity in the field of pharmacoepidemiology.

Original languageEnglish (US)
Title of host publicationPharmacoepidemiology, Fifth Edition
PublisherWiley-Blackwell
Pages107-116
Number of pages10
ISBN (Print)0470654759, 9780470654750
DOIs
StatePublished - Jan 3 2012
Externally publishedYes

Fingerprint

Pharmacoepidemiology
Information Storage and Retrieval
Capacity Building
Pharmaceutical Preparations
Industry
Growth

Keywords

  • Drug safety
  • Evidence-based decision making
  • Regulatory agency

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Pan, G. J. D., & Arlett, P. (2012). The Role of Pharmacoepidemiology in Regulatory Agencies. In Pharmacoepidemiology, Fifth Edition (pp. 107-116). Wiley-Blackwell. https://doi.org/10.1002/9781119959946.ch8

The Role of Pharmacoepidemiology in Regulatory Agencies. / Pan, Gerald J Dal; Arlett, Peter.

Pharmacoepidemiology, Fifth Edition. Wiley-Blackwell, 2012. p. 107-116.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pan, GJD & Arlett, P 2012, The Role of Pharmacoepidemiology in Regulatory Agencies. in Pharmacoepidemiology, Fifth Edition. Wiley-Blackwell, pp. 107-116. https://doi.org/10.1002/9781119959946.ch8
Pan GJD, Arlett P. The Role of Pharmacoepidemiology in Regulatory Agencies. In Pharmacoepidemiology, Fifth Edition. Wiley-Blackwell. 2012. p. 107-116 https://doi.org/10.1002/9781119959946.ch8
Pan, Gerald J Dal ; Arlett, Peter. / The Role of Pharmacoepidemiology in Regulatory Agencies. Pharmacoepidemiology, Fifth Edition. Wiley-Blackwell, 2012. pp. 107-116
@inbook{1424104265b74f55ad19395abae2d619,
title = "The Role of Pharmacoepidemiology in Regulatory Agencies",
abstract = "The data sources and methods that underlie the discipline of pharmacoepidemiology have expanded greatly over the past several decades. This growth has involved academia, industry, and regulatory agencies. For drug regulatory agencies, pharmacoepidemiology is a core scientific discipline. Three key issues are highlighted that are of particular importance to drug regulators: using pharmacoepidemiology throughout a product's lifecycle; developing approaches to synthesize data from multiple sources; and building capacity in the field of pharmacoepidemiology.",
keywords = "Drug safety, Evidence-based decision making, Regulatory agency",
author = "Pan, {Gerald J Dal} and Peter Arlett",
year = "2012",
month = "1",
day = "3",
doi = "10.1002/9781119959946.ch8",
language = "English (US)",
isbn = "0470654759",
pages = "107--116",
booktitle = "Pharmacoepidemiology, Fifth Edition",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - The Role of Pharmacoepidemiology in Regulatory Agencies

AU - Pan, Gerald J Dal

AU - Arlett, Peter

PY - 2012/1/3

Y1 - 2012/1/3

N2 - The data sources and methods that underlie the discipline of pharmacoepidemiology have expanded greatly over the past several decades. This growth has involved academia, industry, and regulatory agencies. For drug regulatory agencies, pharmacoepidemiology is a core scientific discipline. Three key issues are highlighted that are of particular importance to drug regulators: using pharmacoepidemiology throughout a product's lifecycle; developing approaches to synthesize data from multiple sources; and building capacity in the field of pharmacoepidemiology.

AB - The data sources and methods that underlie the discipline of pharmacoepidemiology have expanded greatly over the past several decades. This growth has involved academia, industry, and regulatory agencies. For drug regulatory agencies, pharmacoepidemiology is a core scientific discipline. Three key issues are highlighted that are of particular importance to drug regulators: using pharmacoepidemiology throughout a product's lifecycle; developing approaches to synthesize data from multiple sources; and building capacity in the field of pharmacoepidemiology.

KW - Drug safety

KW - Evidence-based decision making

KW - Regulatory agency

UR - http://www.scopus.com/inward/record.url?scp=84883152757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883152757&partnerID=8YFLogxK

U2 - 10.1002/9781119959946.ch8

DO - 10.1002/9781119959946.ch8

M3 - Chapter

AN - SCOPUS:84883152757

SN - 0470654759

SN - 9780470654750

SP - 107

EP - 116

BT - Pharmacoepidemiology, Fifth Edition

PB - Wiley-Blackwell

ER -